Elder Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
as on 04-05-2024
- Paid Up Capital ₹ 20.54 Cr
as on 04-05-2024
- Company Age 41 Year, 8 Months
- Last Filing with ROC 30 Jun 2013
- Open Charges ₹ 338.10 Cr
as on 04-05-2024
- Satisfied Charges ₹ 3,335.92 Cr
as on 04-05-2024
About Elder Pharmaceuticals
- CIN/LLPIN
L24239MH1983PLC029714
- Company No.
029714
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 Apr 1983
- Date of AGM
30 Dec 2013
- Date of Balance Sheet
30 Jun 2013
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Elder Pharmaceuticals Limited offer?
Elder Pharmaceuticals Limited offers a wide range of products and services, including Skin Care, Bath Essentials, Popular Category, Sexual Wellness, Sunscreen Products, Hair Care, Shampoo, Vitamins & Supplements, Mineral Supplements, Hair Conditioners.
Who are the key members and board of directors at Elder Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alok Saxena  | Managing Director | 29-Aug-2002 | Current |
| Vijendra Jain | Company Secretary | 15-May-2014 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abdul Ravani | Additional Director | 25-Jan-2016 | Current |
| Kader Davawala | Additional Director | 25-Jan-2016 | Current |
Financial Performance and Corporate Structure Insights of Elder Pharmaceuticals.
Enhance accessibility to Elder Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Elder Pharmaceuticals?
Unlock access to Elder Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Dcb Bank Limited Creation Date: 10 Oct 2014 | ₹16.00 Cr | Open |
Bank Of India Creation Date: 30 Jul 2014 | ₹35.00 Cr | Open |
Axis Trustee Services Limited Creation Date: 19 Nov 2012 | ₹70.00 Cr | Open |
How Many Employees Work at Elder Pharmaceuticals?
Elder Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elder Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elder Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
